Song Lin

Song Lin is a notable inventor based in Xiamen, China. He has made significant contributions to the field of biotechnology, particularly in the development of modified interferon therapies. His work has implications for medical treatments and showcases the potential of innovative biopharmaceuticals.

Latest Patents

One of Song Lin's key patents is titled "Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof." This invention relates to interferon (IFN)-α2a that is modified at a specific Lys residue with a Y-shaped branched polyethylene glycol (PEG) derivative. The patent outlines the preparation methods for this modified interferon and its applications in medicine, highlighting its potential to enhance therapeutic efficacy.

Career Highlights

Song Lin is currently associated with Biosteed Gene Expression Tech. Co., Ltd., where he continues to advance his research and development efforts. His work in the biotechnology sector has positioned him as a key figure in the innovation of therapeutic agents.

Collaborations

Throughout his career, Song Lin has collaborated with notable colleagues, including Weidong Zhou and Qingjiang Xiao. These partnerships have fostered a collaborative environment that enhances the research and development of innovative biopharmaceuticals.

Conclusion

Song Lin's contributions to the field of biotechnology, particularly through his patented innovations, demonstrate the importance of research in developing effective medical treatments. His work continues to inspire advancements in the industry.

Profile summary based on public USPTO records.